ASO Visual Abstract: Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? : A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens.

Authors

Javier I J Orozco, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USAFollow
Shu-Ching Chang, Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Saint Joseph Health, Portland, OR, USAFollow
Chikako Matsuba, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USAFollow
Miquel Ensenyat-Mendez
Gary L Grunkemeier, Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Saint Joseph Health, Portland, OR, USAFollow
Diego M Marzese
Janie G Grumley, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USAFollow

Document Type

Article

Publication Date

8-25-2021

Publication Title

Annals of surgical oncology : the official journal of the Society of Surgical Oncology

Keywords

california; santa monica; jwci; sjci; psjhc; oregon; portland

Clinical Institute

Cancer

Department

Oncology

Department

Surgery

Recommended Citation

Orozco, Javier I J; Chang, Shu-Ching; Matsuba, Chikako; Ensenyat-Mendez, Miquel; L Grunkemeier, Gary; Marzese, Diego M; and Grumley, Janie G, "ASO Visual Abstract: Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? : A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens." (2021). Articles, Abstracts, and Reports. 5175.
https://digitalcommons.providence.org/publications/5175